FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology, and represents a composition of high-molecular heparin and fish oil Eiconol exhibiting properties for oral application differing by the fact that it additionally contains leucine in the following amounts of the ingredients at 90-120 IU of heparin activity: leucine - 0.56-0.58 mg, Eiconol -113-115 mg.
EFFECT: invention provides more evident anticoagulant, anti-plate, fibrinolytic and fibrin depolymerisation action in single oral administration.
3 cl, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HIGH-MOLECULAR HEPARIN COMPOSITION WITH ANTICOAGULANT, ANTI-PLATELET, FIBRINOLYTIC AND FIBRIN DEPOLYMERISATION PROPERTIES | 2011 |
|
RU2456993C1 |
| ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
| ANTITHROMBOTIC COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2600817C2 |
| METHOD FOR MAKING ANTICOAGULANT-FIBRINOLYTIC HEPARIN PREPARATION | 2011 |
|
RU2448717C1 |
| ANTICOAGULANT, ANTIPLATELET AND FIBRIN-DEPOLYMERIZATION COMPLEX BASED ON HEPARIN, METHOD OF ITS PRODUCTION AND USE | 2015 |
|
RU2606836C2 |
| AGENT POSSESSING ANTI-COAGULATING, ANTI-THROMBOCYTIC, ANTI-THROMBOSIS, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC ACTIVITY | 2005 |
|
RU2290195C1 |
| ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
| ANTI-THROMBOSIS, ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, FIBRINOLYTIC AGENT FOR INTRAMUSCULAR ADMINISTRATION | 2005 |
|
RU2288737C1 |
| ANTI-THROMBOSIS, ANTI-COAGULATING, FIFRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT FOR INTRANASAL ADMINISTRATION | 2005 |
|
RU2290193C1 |
| ANTICOAGULANT | 2016 |
|
RU2610433C1 |
